- Assistance Publique Hôpitaux de Paris and Réseau des acheteurs hospitaliers d'Ile de France Sign Agreement with Omnicell, Strengthening Commitment to Patient Safety in France
MOUNTAIN VIEW, California, March 12, 2013 /PRNewswire/ -- Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication and supply management solutions and analytics software for healthcare facilities, and its partner EURAF, a leader in France for the medical equipment critical to medication distribution in hospital pharmacies, announced the awarding of a four-year preferred vendor agreement to source OmniRx® G4 automated medication dispensing cabinets without tender to the Assistance Publique Hôpitaux de Paris (AP-HP) and Réseau des acheteurs hospitaliers d'Ile de France (RESAH-IDF). The French healthcare organizations selected Omnicell's G4 technology over competitive options because of its easy scalability to meet the varied medication automation needs of their numerous and diverse hospitals.
Standard bearers for medical excellence in Europe, AP-HP and RESAH-IDF are internationally recognized for their commitment to patient medication safety. AP-HP is the largest university hospital system in Europe, serving the city of Paris and its suburbs. It employs more than 90,000 people (including 22,000 physicians) in 44 hospitals and receives more than 7 million annual patient visits. RESAH-IDF is a group purchasing organization in the Ile de France region that has more than 120 members responsible for more than 42,000 hospital beds.
"EURAF is delighted by this agreement with AP-HP and RESAH-IDF," said Jean-Baptiste Guillot, general manager at EURAF. "Today, AP-HP and RESAH-IDF member hospitals reinforced their reputation as one of the most prestigious healthcare delivery systems in Europe. Their commitment to patient safety is reflected in their selection of Omnicell's advanced G4 medication automation technology which ensures the right medication is securely delivered to the right patient at the right moment."
The landmark AP-HP and RESAH-IDF agreement is a reflection of the strength of Omnicell's technology and low cost of ownership, as well as EURAF's strong reputation as a French leader in customer service. AP-HP and RESAH-IDF reported that their purchasing decisions were strongly influenced by Omnicell's flexible OmniRx G4 automated medication dispensing cabinets (ADCs), which can be configured to meet the diverse medication and security needs of any patient care setting. In addition to this flexibility, Omnicell's ADCs are modular and easily upgraded to keep the cost of investment low.
"Omnicell and EURAF are long time partners whose joint efforts with AP-HP and RESAH-IDF will help to ensure safer delivery of medical care in France," said Don Ferren, director of International Sales at Omnicell. "EURAF is trusted by hospitals and healthcare organizations throughout France as the best in customer support. Omnicell is very pleased to join with EURAF to deliver the benefits of our industry leading medication automation technology to the French patients served by the AP-HP and RESAH-IDF."
EURAF provides solutions for medication delivery, such as automated dispensing cabinets, automated tablet dispensing systems, and unidose packaging machines. Considered the reference on the French market, EURAF has over 10 years of solid experience in project management and customer service.
Omnicell, Inc. (NASDAQ: OMCL) is a leading provider of automation and business information solutions enabling hospitals and other healthcare organizations to streamline the medication administration process and manage costly medical supplies for increased operational efficiency and enhanced patient safety. Through seamless integration with a customer's existing IT infrastructure, Omnicell solutions empower healthcare facilities to achieve comprehensive automation of medication and supply management from the arrival at the loading dock to the patient's bedside. Omnicell also provides healthcare facilities with business analytics software designed to improve medication diversion detection and regulatory compliance.
Since 1992, more than 2,600 hospital customers worldwide have utilized Omnicell's medication automation, supply chain, and analytics solutions to enable them to increase patient safety, improve efficiency and address changing healthcare regulations while providing effective control of costs, charge capture for payer reimbursement and inventory management of medications and supplies.
MTS Medication Technologies, a wholly-owned Omnicell subsidiary, is a leader in medication adherence packaging systems designed to improve medication dispensing and administration. MTS enables approximately 6,000 institutional and retail pharmacies worldwide to maintain high accuracy and quality standards while optimizing productivity and controlling costs. The MTS product line includes more than 20 packaging machines and 50 types of consumable products.
OMCL - G
1. Omnicell news releases (financial, acquisitions, products, technology etc.) are issued exclusively by PR Newswire and are immediately thereafter posted on the company's external website, omnicell.com.
2. Omnicell and the Omnicell logo design are registered trademarks of Omnicell, Inc. OptiFlex is a trademark of Omnicell, Inc.
3. All other brand or product names may be trademarks or registered trademarks of its respective companies.
SOURCE Omnicell, Inc.